Launch date: March 2018
The Dexcom G6 is the company’s latest CGM system, and it includes several new technologies and capabilities. Most prominently, it’s the first FDA-approved CGM device that can communicate with insulin pumps designed to adjust your dose of insulin based on CGM readings (such as the t:slim X2 Insulin Pump, previous page).
The G6 is also approved for use as a standalone device to make treatment decisions based on your glucose level — without the need for fingerstick tests before taking action. Fingerstick tests also aren’t needed to calibrate the device.
The company has also redesigned its sensor applicator to make insertion easier, and sensors can now be worn for 10 days at a time. The new transmitter is 28 percent lower in profile than previous Dexcom transmitters.
The device can also issue what’s known as a Predictive Low Alert when it senses that your blood glucose will soon be dangerously low. As with previous generations of Dexcom CGM systems, the G6 can automatically send your glucose readings to a compatible smart device every 5 minutes.